TD Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.03M | Buy |
|
|||||
|
2025
Q1 | $3.62M | Sell |
|
|||||
|
2024
Q4 | $9.58M | Buy |
|
|||||
|
2024
Q3 | $3.91M | Sell |
|
|||||
|
2024
Q2 | $3.66M | Buy |
|
|||||
|
2024
Q1 | $3.14M | Sell |
|
|||||
|
2023
Q4 | $2.37M | Buy |
|
|||||
|
2023
Q3 | $2.29M | Sell |
|
|||||
|
2023
Q2 | $1.7M | Sell |
|
|||||
|
2023
Q1 | $2.01M | Sell |
|
|||||
|
2022
Q4 | $2.1M | Sell |
|
|||||
|
2022
Q3 | $1.83M | Sell |
|
|||||
|
2022
Q2 | $1.82M | Sell |
|
|||||
|
2022
Q1 | $2.33M | Buy |
|
|||||
|
2021
Q4 | $1.94M | Sell |
|
|||||
|
2021
Q3 | $2.42M | Sell |
|
|||||
|
2021
Q2 | $2.44M | Buy |
|
|||||
|
2021
Q1 | $2.86M | Buy |
|
|||||
|
2020
Q4 | $2.37M | Buy |
|
|||||
|
2020
Q3 | $2.2M | Buy |
|
|||||
|
2020
Q2 | $2.93M | Sell |
|
|||||
|
2020
Q1 | $2.17M | Sell |
|
|||||
|
2019
Q4 | $2.4M | Sell |
|
|||||
|
2019
Q3 | $2.13M | Sell |
|
|||||
|
2019
Q2 | $2.92M | Buy |
|
|||||
|
2019
Q1 | $4.58M | Buy |
|
|||||
|
2018
Q4 | $4.33M | Buy |
|
|||||
|
2018
Q3 | $5.95M | Buy |
|
|||||
|
2018
Q2 | $6.57M | Buy |
|
|||||
|
2018
Q1 | $4.19M | Buy |
|
|||||
|
2017
Q4 | $4.62M | Sell |
|
|||||
|
2017
Q3 | $5.6M | Sell |
|
|||||
|
2017
Q2 | $73.1M | Buy |
|
|||||
|
2017
Q1 | $67.5M | Sell |
|
|||||
|
2016
Q4 | $78.6M | Buy |
|
|||||
|
2016
Q3 | $88.7M | Buy |
|
|||||
|
2016
Q2 | $95.5M | Buy |
|
|||||
|
2016
Q1 | $83.9M | Sell |
|
|||||
|
2015
Q4 | $117M | Buy |
|
|||||
|
2015
Q3 | $66.3M | Buy |
|
|||||
|
2015
Q2 | $13.2M | Sell |
|
|||||
|
2015
Q1 | $26.9M | Buy |
|
|||||
|
2014
Q4 | $14.9M | Buy |
|
|||||
|
2014
Q3 | $13.5M | Sell |
|
|||||
|
2014
Q2 | $13.4M | Buy |
|
|||||
|
2014
Q1 | $8.57M | Sell |
|
|||||
|
2013
Q4 | $8.41M | Sell |
|
|||||
|
2013
Q3 | $16.4M | Buy |
|
|||||
|
2013
Q2 | $14.9M | Buy |
|